KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Assets (2016 - 2025)

Pacific Biosciences Of California (PACB) has 15 years of Return on Assets data on record, last reported at 0.69% in Q4 2025.

  • For Q4 2025, Return on Assets fell 46.0% year-over-year to 0.69%; the TTM value through Dec 2025 reached 0.69%, down 46.0%, while the annual FY2025 figure was 0.53%, 33.0% down from the prior year.
  • Return on Assets reached 0.69% in Q4 2025 per PACB's latest filing, down from 0.62% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.05% in Q3 2021 and bottomed at 0.69% in Q4 2025.
  • Average Return on Assets over 5 years is 0.25%, with a median of 0.17% recorded in 2023.
  • Peak YoY movement for Return on Assets: surged 42bps in 2021, then tumbled -46bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.06% in 2021, then plummeted by -174bps to 0.18% in 2022, then grew by 4bps to 0.17% in 2023, then crashed by -36bps to 0.23% in 2024, then crashed by -201bps to 0.69% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.69% in Q4 2025, 0.62% in Q3 2025, and 0.62% in Q2 2025.